John Le Gall
About John Le Gall
John Le Gall is a Senior Director of Oncology at Instil Bio, where he has worked since 2020. He has a background in medical leadership and training, having held positions at Kite Pharma and the National Cancer Institute, and holds degrees from Columbia University and Johns Hopkins University.
Current Role at Instil Bio
John Le Gall serves as the Senior Director of Oncology at Instil Bio, a position he has held since 2020. His role involves overseeing oncology programs and contributing to the development of innovative cancer therapies. Based in Los Angeles, California, he plays a critical part in advancing the company's mission to improve patient outcomes through targeted treatments.
Previous Experience at Kite Pharma
Before joining Instil Bio, John Le Gall worked at Kite Pharma as the Medical Director of Clinical Development from 2018 to 2020. During his tenure in Santa Monica, California, he focused on the development of cell therapies for cancer treatment, contributing to the company's efforts in advancing innovative oncology solutions.
Experience at National Cancer Institute
John Le Gall was a Postdoctoral Clinical Fellow in Immunotherapy at the National Cancer Institute (NCI) from 2015 to 2018. Based in Bethesda, Maryland, he engaged in research and clinical trials aimed at enhancing immunotherapy approaches for cancer treatment, furthering his expertise in the field.
Educational Background
John Le Gall holds an MD from Columbia University College of Physicians and Surgeons, where he studied from 2007 to 2012. He also earned an MBA from Columbia Business School in 2012. Additionally, he completed a BS/MS at Johns Hopkins University from 2002 to 2007, and attended Phillips Exeter Academy from 1998 to 2002.
Fellowship at Johns Hopkins Hospital
John Le Gall completed a fellowship in Pediatric Oncology and Hematology at Johns Hopkins Hospital from 2015 to 2018. During this time in Baltimore, Maryland, he gained specialized training in treating pediatric cancer patients, enhancing his clinical expertise in oncology.